Sort by
Fracture of the Frontal Sinus: Complexity of a Multidisciplinary Treatment
Vinicius Arruda Vasconcelos,
Lucas Cavalieri Pereira,
Ana Júlia Coral,
Laura Diaz,
Bruno Nifosi Prado
Study Design: A retrospective study Objective: This study aims to retrospectively present our experience in the management of frontal sinus fractures, thus understanding the entire epidemiology of fractures and guiding us in the best form of treatment. Methods: The medical records of patients with frontal sinus fractures, which occurred from 2017 to 2024 (8 years), in the city os Piracicaba (423.000 inhabitants), State od São Paulo (Brazil), involving three trauma reference hospitals in the region. These patients were diagnosed and treated by the same Oral and Maxillofacial Surgery team. Results: we obtained the number of 40 patients, with ages ranging from 1 to 89 years, and an average age of 41 years. There was a predominance of the male sex with 39 cases and only 1 case of the female. After establishing the diagnosis, 22 patients received conservative treatment, while 18 patients were treated surgically (45%). The predominant etiology of the fractures was traffic accidents, accounting for 15 patients (37.5%). Conclusions: An analysis of data relating to frontal sinus fractures revealed a higher prevalence among male patients, with an average age of 41 years. The main causal factor identified was traffic accidents, which represented the majority of cases. Not that it refers to treatment, the conservative approach was the most commonly adopted. Furthermore, case review did not indicate the occurrence of complications during follow-up, resulting in recovery without the need for additional interventions.
Study Design: A retrospective study Objective: This study aims to retrospectively present our experience in the management of frontal sinus fractures, thus understanding the entire epidemiology of fractures and guiding us in the best form of treatment. Methods: The medical records of patients with frontal sinus fractures, which occurred from 2017 to 2024 (8 years), in the city os Piracicaba (423.000 inhabitants), State od São Paulo (Brazil), involving three trauma reference hospitals in the region. These patients were diagnosed and treated by the same Oral and Maxillofacial Surgery team. Results: we obtained the number of 40 patients, with ages ranging from 1 to 89 years, and an average age of 41 years. There was a predominance of the male sex with 39 cases and only 1 case of the female. After establishing the diagnosis, 22 patients received conservative treatment, while 18 patients were treated surgically (45%). The predominant etiology of the fractures was traffic accidents, accounting for 15 patients (37.5%). Conclusions: An analysis of data relating to frontal sinus fractures revealed a higher prevalence among male patients, with an average age of 41 years. The main causal factor identified was traffic accidents, which represented the majority of cases. Not that it refers to treatment, the conservative approach was the most commonly adopted. Furthermore, case review did not indicate the occurrence of complications during follow-up, resulting in recovery without the need for additional interventions.
Posted: 14 February 2025
Congenital Oropouche in Humans: Clinical Characterization of a Possible New Teratogenic Syndrome
Bethânia FR Ribeiro,
André Rodrigues Façanha Barreto,
Andre Pessoa,
Raimunda do Socorro da Silva Azevedo,
Flávia de Freitas Rodrigues,
Bruna da Cruz Beyruth Borges,
Natália Pimentel Moreno Mantilla,
Davi Dantas Muniz,
Jannifer Oliveira Chiang,
Lucas Rosa Fraga
Posted: 13 February 2025
Concizumab, a Non-replacement Therapy for Persons with Hemophilia with Inhibitors
Giancarlo Castaman,
Victor Jimenez-Yuste,
Johnny Mahlangu
Posted: 13 February 2025
Hypoalbuminemia as a Predictor of Mortality in Patients with Septic Shock: A Retrospective Study
Alexis Yael Cortéz-Martínez,
Umbilia Aranet Chávez-Guzmán,
Santos Ramírez-Medina,
Angélica Georgina Rocha-López
Posted: 13 February 2025
Repurposing Antiepileptic Drugs for Cancer: A Promising Therapeutic Strategy
Noor Tarawneh,
Shaymaa N Hussein,
Shtaywy Abdalla
Posted: 13 February 2025
Right Ventricular and Left Atrial Strain Predict Volumetric Response to Cardiac Resynchronization Therapy
Shing Ching,
Jeffrey Ji-Peng Li,
Stefanie Maria Werhahn,
Rebecca Elisabeth Beyer,
Misael Estepa Martinez,
Christian Stehning,
Djawid Hashemi,
Natalja Solowjowa,
Christoph Klein,
Henryk Dreger
Posted: 13 February 2025
A Narrative Review Of Minimal Hepatic Encephalopathy
Jamir Pitton Rissardo,
Ibrahim Khalil,
Reem Sayad,
Ahmed M. Kedwany,
Hager Hamdy Sayed,
Abhishek A. Chouthai,
Ana Letícia Fornari Caprara
Posted: 13 February 2025
Various Phenotypes of Ectopic Pancreatic Tissue in Children: Case Series and Literature Review
Roxana Elena Matran,
Andra Mihaela Diaconu,
Oana Neagu,
Alexandru Ioan Ulmeanu
Background/Objectives: Ectopic pancreatic tissue (EPT), an infrequently documented condition within the pediatric population, is often asymptomatic. When clinical manifestations do occur, their severity is contingent upon the location, size, and involvement of the adjacent mucosa. Methods: This is a case series study, involving children aged 15 days – 13 years diagnosed with EPT from one single institution. Results: Six cases of EPT were identified. Five of the 6 cases presented with both EPT and ectopic gastric tissue, located at the site of Meckel’s diverticulum, while 1 case presented EPT exclusively and it was localized in the duodenum I. A case of Littre’s hernia was identified in a newborn. Two of the 6 cases experienced gastrointestinal bleeding. Conclusions: The identification of EPT continues to pose a diagnostic challenge, as the symptoms are nonspecific and can sometimes be life-threatening. Additionally, there are currently no specific paraclinical investigations available for this purpose.
Background/Objectives: Ectopic pancreatic tissue (EPT), an infrequently documented condition within the pediatric population, is often asymptomatic. When clinical manifestations do occur, their severity is contingent upon the location, size, and involvement of the adjacent mucosa. Methods: This is a case series study, involving children aged 15 days – 13 years diagnosed with EPT from one single institution. Results: Six cases of EPT were identified. Five of the 6 cases presented with both EPT and ectopic gastric tissue, located at the site of Meckel’s diverticulum, while 1 case presented EPT exclusively and it was localized in the duodenum I. A case of Littre’s hernia was identified in a newborn. Two of the 6 cases experienced gastrointestinal bleeding. Conclusions: The identification of EPT continues to pose a diagnostic challenge, as the symptoms are nonspecific and can sometimes be life-threatening. Additionally, there are currently no specific paraclinical investigations available for this purpose.
Posted: 13 February 2025
Marine Bioactive Compounds: Fucoidans and Fucoxanthin, Their Potential Use in Age-Related Macular Degeneration
Lidianys María Lewis-Luján,
María Elena Ochoa Hernandez,
Juan Carlos Galvez-Ruiz,
Nesty Olivares Arzuaga,
María Guadalupe Burboa-Zazueta,
Sergio Trujillo-Lopez,
Mark Frederick McCarty,
Simon Bernard Iloki-Assanga
Posted: 13 February 2025
FAPi PET/CT Imaging to Identify Fibrosis in Immune-Mediated Inflammatory Diseases
Dalia A. Lartey,
Lynn A. Schilder,
Gerben J.C. Zwezerijnen,
Geert Renaat Alfons Maria D'Haens,
Joep Grootjans,
Mark Löwenberg
Immune-mediated inflammatory diseases (IMIDs) are characterized by chronic systemic inflammation and multiorgan involvement. Fibrosis formation in IMIDs can cause tissue destruction and subsequently organ malfunction. Fibroblast activation protein inhibitor positron emission tomography/computed tomography (FAPi PET/CT) represents a novel imaging technique that holds great potential to visualize in vivo fibrosis. We here provide an overview of available evidence on FAPi PET/CT imaging to visualize fibrosis in var-ious IMIDs, including interstitial lung diseases, Immunoglobulin G4-related diseases, cardiovascular diseases, kidney diseases and gastrointestinal diseases. FAPi PET/CT imaging demonstrates high sensitivity in detecting early fibrosis, correlating with dis-ease severity, across different IMIDs, showing superiority compared to conventional imaging modalities. Although FAPi PET/CT might be a useful tool to assess fibrosis formation, thereby aiding in grading disease severity and staging, future studies should include larger sample sizes in a broad variety of IMIDs with emphasis on the optimiza-tion of imaging protocols to further validate its diagnostic value.
Immune-mediated inflammatory diseases (IMIDs) are characterized by chronic systemic inflammation and multiorgan involvement. Fibrosis formation in IMIDs can cause tissue destruction and subsequently organ malfunction. Fibroblast activation protein inhibitor positron emission tomography/computed tomography (FAPi PET/CT) represents a novel imaging technique that holds great potential to visualize in vivo fibrosis. We here provide an overview of available evidence on FAPi PET/CT imaging to visualize fibrosis in var-ious IMIDs, including interstitial lung diseases, Immunoglobulin G4-related diseases, cardiovascular diseases, kidney diseases and gastrointestinal diseases. FAPi PET/CT imaging demonstrates high sensitivity in detecting early fibrosis, correlating with dis-ease severity, across different IMIDs, showing superiority compared to conventional imaging modalities. Although FAPi PET/CT might be a useful tool to assess fibrosis formation, thereby aiding in grading disease severity and staging, future studies should include larger sample sizes in a broad variety of IMIDs with emphasis on the optimiza-tion of imaging protocols to further validate its diagnostic value.
Posted: 13 February 2025
The Cancer and Work Scale (CAWSE): Development and Validation of a Return to Work Assessment for Cancer
Christine Maheu,
Mina Singh,
Wing Lam Tock,
Jennifer Robert,
Andrea Vodermaier,
Maureen Parkinson,
Naomi Dolgoy
Posted: 13 February 2025
The Effect of Sensory Integration on Neuroplasticity and Functional Recovery in Neurological Patients
Myrto Patagia Bakaraki
This study examines the impact of SI-based treatments on neuroplastic alterations and functional recovery in persons with acquired neurological disorders. We quantify cortical remodeling following organized sensory-based therapies using standardized functional evaluations and functional magnetic resonance imaging (fMRI). Proprioceptive, vestibular, and tactile inputs are used in designed SI activities to integrate sensory-motor skills. Changes in sensorimotor network activation, enhancements in activities of daily living (ADLs), and general functional independence are examples of outcome measures. The function of SI in adult neurological rehabilitation has not been thoroughly investigated, despite its extensive usage in developmental disorders. In diseases including multiple sclerosis (MS), traumatic brain injury (TBI), and stroke, neuroplasticity—the brain's capacity to rearrange itself in response to experience or injury—is a crucial rehabilitation process. The objective of this research is to develop a novel method of neurological rehabilitation by fusing SI concepts with contemporary neuroscience. The results will strengthen the body of evidence supporting sensory-based therapies to promote functional neuroplasticity. Additionally, the study will give doctors a foundation for using SI in adult rehabilitation settings. This effort will demonstrate the potential of SI to enhance recovery trajectories for individuals with stroke, TBI, and MS, bridging the gap between occupational therapy and neuroscience. Long-term impacts and the integration of SI into multimodal rehabilitation programs should be the focus of future research.
This study examines the impact of SI-based treatments on neuroplastic alterations and functional recovery in persons with acquired neurological disorders. We quantify cortical remodeling following organized sensory-based therapies using standardized functional evaluations and functional magnetic resonance imaging (fMRI). Proprioceptive, vestibular, and tactile inputs are used in designed SI activities to integrate sensory-motor skills. Changes in sensorimotor network activation, enhancements in activities of daily living (ADLs), and general functional independence are examples of outcome measures. The function of SI in adult neurological rehabilitation has not been thoroughly investigated, despite its extensive usage in developmental disorders. In diseases including multiple sclerosis (MS), traumatic brain injury (TBI), and stroke, neuroplasticity—the brain's capacity to rearrange itself in response to experience or injury—is a crucial rehabilitation process. The objective of this research is to develop a novel method of neurological rehabilitation by fusing SI concepts with contemporary neuroscience. The results will strengthen the body of evidence supporting sensory-based therapies to promote functional neuroplasticity. Additionally, the study will give doctors a foundation for using SI in adult rehabilitation settings. This effort will demonstrate the potential of SI to enhance recovery trajectories for individuals with stroke, TBI, and MS, bridging the gap between occupational therapy and neuroscience. Long-term impacts and the integration of SI into multimodal rehabilitation programs should be the focus of future research.
Posted: 13 February 2025
SARS-CoV-2 and Mental Health: A Cross-Sectional Study of Young Individuals with Mild to Moderate COVID-19, an Average of 15 Months Post-Recovery
Ashkan Latifi
Posted: 13 February 2025
The Prevalence of pks+ E. coli in Cystic Fibrosis
Christopher Chan,
Michael Coffey,
Caitlin Murphy,
Isabelle McKay,
Jumaana Abdu,
Keerti Paida,
Rachel Y. Tam,
Hannah Wrigley-Carr,
Bernadette Prentice,
Louisa Owens
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer, but pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is impli-cated in intestinal carcinogenesis via production of colibactin, however relevance in CF is unknown. We investigated pks+ E. coli prevalence in CF at baseline and longitudinally, performing PCR on stool DNA extracts. Potential associations between pks+ E. coli and gastrointestinal inflammation or microbiome dynamics were analysed using faecal calprotectin and 16SrRNA gene taxonomic data. At baseline, no difference in pks+ E. coli carriage was identified between CF and healthy controls, 21/55(38%) vs 26/55(47%), p=0.32. Pks+ E. coli was not associated with significant differences in mean (SD) calpro-tectin concentration (124(154) vs 158(268) mg/kg; p=0.60), microbial richness (159(76.5) vs 147(70.4); p=0.50) or Shannon diversity index (2.78(0.77) vs 2.65(0.74); p=0.50) in CF. Lon-gitudinally, subjects demonstrated intra-individual variation in pks+ E. coli presence, however no significant difference in overall prevalence was observed. Thus, intesti-nal pks+ E. coli prevalence was not different between CF and healthy controls, nor associ-ated with differences in gut microbial profile or inflammation. Investigating effects of re-peat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
Cystic fibrosis (CF) patients experience higher risks of colorectal cancer, but pathogenesis is unclear. In the general population, polyketide synthase-positive (pks+) E. coli is impli-cated in intestinal carcinogenesis via production of colibactin, however relevance in CF is unknown. We investigated pks+ E. coli prevalence in CF at baseline and longitudinally, performing PCR on stool DNA extracts. Potential associations between pks+ E. coli and gastrointestinal inflammation or microbiome dynamics were analysed using faecal calprotectin and 16SrRNA gene taxonomic data. At baseline, no difference in pks+ E. coli carriage was identified between CF and healthy controls, 21/55(38%) vs 26/55(47%), p=0.32. Pks+ E. coli was not associated with significant differences in mean (SD) calpro-tectin concentration (124(154) vs 158(268) mg/kg; p=0.60), microbial richness (159(76.5) vs 147(70.4); p=0.50) or Shannon diversity index (2.78(0.77) vs 2.65(0.74); p=0.50) in CF. Lon-gitudinally, subjects demonstrated intra-individual variation in pks+ E. coli presence, however no significant difference in overall prevalence was observed. Thus, intesti-nal pks+ E. coli prevalence was not different between CF and healthy controls, nor associ-ated with differences in gut microbial profile or inflammation. Investigating effects of re-peat exposure on risk profile and analysis of older CF cohorts is necessary to identify if associations with colorectal cancer exist.
Posted: 13 February 2025
Mirtazapine as a Potential Therapy for Post-COVID-19 Syndrome (Long COVID): A Comprehensive Review
Marcos Altable
Posted: 13 February 2025
Expanded Spectrum and Increased Incidence of Adverse Events Linked to COVID-19 Genetic Vaccines: New Concepts on Prophylactic Immuno-Gene Therapy, Iatrogenic Orphan Disease and Platform-Inherent Challenges
Janos Szebeni
The mRNA- and DNA-based “genetic” COVID-19 vaccines can induce a broad range of adverse events (AEs), with statistics showing significant variation depending on timing and data analysis methods. Focusing only on lipid nanoparticle-enclosed mRNA (mRNA-LNP) vaccines, this review traces the evolution of statistical conclusions on AE prevalence and incidence associated with these vaccines, from initial underestimation of atypical, severe toxicities to recent claims suggesting the possible contribution of Covid-19 vaccinations to the excess deaths observed in many countries over the past few years. Among hundreds of different AEs listed in Pfizer’s pharmacovigilance survey, the present analysis categorizes the main symptoms according to organ systems, nearly all being affected. Using data from the US Vaccine Adverse Event Reporting System and a global vaccination dataset, a comparison of the prevalence and incidence rates of AEs induced by genetic versus flu vaccines revealed an average 26-fold increase in AEs with genetic vaccines. The difference is especially pronounced in the case of severe ‘Brighton-listed’ AEs, which are also observed in COVID-19 and post-COVID conditions. Among these, the increases of incidence rates relative to flu vaccines, given as x-fold rises, were 1,152x, 455x, 226x, 218x, 162x, 152x; and 131x, for myocarditis, thrombosis, death, myocardial infarction, tachycardia, dyspnea, and hypertension, respectively. The review delineates the concepts that genetic vaccines can be regarded as prophylactic immuno-gene therapies, and that the chronic disabling AEs might be categorized as iatrogenic orphan diseases. It also examines the unique vaccine characteristics that could be causally related to abnormal immune responses potentially leading to adverse events and complications. These new insights may contribute to improving the safety of this platform technology and assessing the risk-benefit balance of various products.
The mRNA- and DNA-based “genetic” COVID-19 vaccines can induce a broad range of adverse events (AEs), with statistics showing significant variation depending on timing and data analysis methods. Focusing only on lipid nanoparticle-enclosed mRNA (mRNA-LNP) vaccines, this review traces the evolution of statistical conclusions on AE prevalence and incidence associated with these vaccines, from initial underestimation of atypical, severe toxicities to recent claims suggesting the possible contribution of Covid-19 vaccinations to the excess deaths observed in many countries over the past few years. Among hundreds of different AEs listed in Pfizer’s pharmacovigilance survey, the present analysis categorizes the main symptoms according to organ systems, nearly all being affected. Using data from the US Vaccine Adverse Event Reporting System and a global vaccination dataset, a comparison of the prevalence and incidence rates of AEs induced by genetic versus flu vaccines revealed an average 26-fold increase in AEs with genetic vaccines. The difference is especially pronounced in the case of severe ‘Brighton-listed’ AEs, which are also observed in COVID-19 and post-COVID conditions. Among these, the increases of incidence rates relative to flu vaccines, given as x-fold rises, were 1,152x, 455x, 226x, 218x, 162x, 152x; and 131x, for myocarditis, thrombosis, death, myocardial infarction, tachycardia, dyspnea, and hypertension, respectively. The review delineates the concepts that genetic vaccines can be regarded as prophylactic immuno-gene therapies, and that the chronic disabling AEs might be categorized as iatrogenic orphan diseases. It also examines the unique vaccine characteristics that could be causally related to abnormal immune responses potentially leading to adverse events and complications. These new insights may contribute to improving the safety of this platform technology and assessing the risk-benefit balance of various products.
Posted: 13 February 2025
Molecular Mechanisms of Iron Metabolism and Overload in Sickle Cell Disease
Aditi Tayal,
Jasmeen Kaur,
Payam Sadeghi,
Robert W. Maitta
Posted: 12 February 2025
FERMENZA: A Patented Natural Alternative to Ketoconazole and Zinc Pyrithione for Managing Dandruff and Scalp Disorders
Munna Bhattacharya,
Sudip Ghosh
Posted: 12 February 2025
Characterizing Plasma-based Metabolomic Signatures for Metastasis in Non-Small Cell Lung Cancer
Manlu Liu,
Yanlong Zhu,
Sean J. McIlwain,
Haotian Deng,
Allan R. Brasier,
Ying Ge,
Michelle E Kimple,
Andrew M. Baschnagel
Posted: 12 February 2025
Epileptic Encephalopathy Related to CAD Deleterious Variants – Time Depending Treatment Initiation - A Case Series
Adelina Glangher,
Magdalena Budisteanu,
Diana Birca,
Dana Surlica,
Florentina-Ionela Linca,
Doina Ioana,
Laurenţiu-Camil Bohîltea,
Ina-Ofelia Focsa,
Catrinel Iliescu
Posted: 12 February 2025
of 738